Overview of the Global Cell & Gene Therapy Drug Delivery Devices Market: Key Statistics and Trends:
According to the latest report by MarkNtel Advisors, titled “Global Cell & Gene Therapy Drug Delivery Devices Market By Product Type (Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe (Size 1.0 ML, 31-Gauge Needle), (Size 0.5 ML, 22-Gauge Needle)), Pre-Filled Syringe (Size 1.0 ML, 22-26 Gauge Needle), (Size 4.0 ML, 22-26 Gauge Needle)), Infusion Bags (Size 10 ML to 50 ML), (Size 68 ML), (Size 60 ML), (Size Up to 65 ML)), By Technology (Microchip Technology, Nano-Technology, Lipid Nanoparticles), By Commercialized Drugs (Luxturna, Kymriah, Yescarta, Zolgensma, Provenge, Strimvelis), By End-Users (Pharmaceuticals & Biotechnology Company, Academic & Research Institute, Hospitals & Clinics), The Global Cell & Gene Therapy Drug Delivery Devices Market is anticipated to grow at a CAGR of around 14% during the forecast period, i.e., 2023-28. The report provides a thorough analysis of the market, covering competitor dynamics, regional insights, and a detailed breakdown of industry segments.
Global Cell & Gene Therapy Drug Delivery Devices Market Growth and Scope:
Base Year: 2022
Forecast Period: 2023-28
Historical Data: 2018-21
CAGR (2023-2028): 14%
Request Free Sample Report (Exclusive Offer on this report): https://www.marknteladvisors.com/query/request-sample/cell-gene-therapy-drug-delivery-devices-market.html
In case you missed it, we are currently revising our reports. Click on the "request sample report" button to get the latest research data with forecast for the years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.
Growth Restraint:
The high costs associated with the manufacturing of cell & gene therapies is the most prominent aspect that might hinder the growth of the Global Cell & Gene Therapy Drug Delivery Devices Market in the coming years.
A Comprehensive Analysis of Leading Companies of Cell & Gene Therapy Drug Delivery Devices Market by MarkNtel Advisors:
- Amgen Inc.
- Bausch & Lomb Incorporated
- Becton, Dickinson and Company
- Bluebird bio Inc.
- Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.)
- Dendreon Pharmaceuticals LLC
- Helixmith Co. Ltd (ViroMed Co., Ltd)
- Human Stem Cells Institute
- Kite Pharma Inc.
- Kolon TissueGene, Inc.
- Novartis AG
- Orchard Therapeutics plc.
- Pfizer Inc.
- Renova Therapeutics
- Spark Therapeutics Inc.
- uniQure N.V.
- Vericel Corporation
Key Cell & Gene Therapy Drug Delivery Devices Market Segmentation:
Explore Our Comprehensive Study: https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html
-By Commercialized Drugs
- Luxturna
- Kymriah
- Yescarta
- Zolgensma
- Provenge
- Strimvelis
Of them all, Luxturna & Yescarta overpowered the Global Cell & Gene Therapy Drug Delivery Devices Market in 2021.
-By Product Type
- Sub-retinal Injection Cannula
- Extension Tube
- Intravenous Catheter
- Sterile Insulin Syringe
- Pre-Filled Syringe
- Infusion Bags
-By Technology
- Microchip Technology
- Nano-Technology
- Lipid Nanoparticles
-By End-User
- Pharmaceuticals & Biotechnology Company
- Academic & Research Institute
- Hospitals & Clinics
Geographical Analysis
-By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia-Pacific
North America attained more than 50% of the revenue share and is anticipated to prevail the same trend in the forecast period.
Key Reports Highlights:
- Market Dimensions & Projections
- Pricing Evaluation,
- Recent Strategic Moves by Companies,
- Primary Stakeholders,
- Analysis of Import and Export Trends,
- Competitive Landscape Assessment,
- Emerging Opportunities,
- Market Trends and Indicators
“Report Delivery Format: Market research reports from MarkNtel Advisors are available in PDF, Excel, and PowerPoint formats. Once payment is successfully processed, the report will be delivered to your email address within 24 hours”
Key Advantages of the Report by MarkNtel Advisors:
- Accurate Revenue Projections: The report provides precise revenue estimates for the market and its key sub segments, benefiting both market leaders and new entrants.
- Strategic Insights for Stakeholders: By understanding the competitive landscape, stakeholders can strategically position their businesses and develop effective go-to-market strategies.
- Comprehensive Market Dynamics Analysis: The report offers valuable insights into the key drivers, restraints, challenges, and opportunities within the market, helping stakeholders make well-informed decisions.
Note: If you need additional information not included in the report, we can customize it to suit your requirements.
Contact Our Analysts for Brochure Requests, Customization, or Any Pre-Purchase Inquiries: https://www.marknteladvisors.com/query/request-customization/cell-gene-therapy-drug-delivery-devices-market.html
About Us –
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
More Research Studies:
- Green Solvents Market size was valued at around USD 1.34 billion in 2024 & is projected to reach USD 1.87 billion by 2028 with a CAGR of around 5.7%.
- The Global Powder Coatings Market is projected to grow from USD 14.30 billion in 2024 to USD 19.38 billion by 2028, at a CAGR of 4.44% during 2025-30.
- Discover the Europe Testing, Inspection & Certification market, projected to grow from USD 59.19 billion in 2024 to USD 78.92 billion by 2028 at a CAGR of 5.92%.
- Biocomposites Market size was valued at around USD 36.9 billion in 2024 and is projected to reach USD 89 billion by 2028 with a CAGR of around 16%.
- The Almond Butter Market is valued at USD 1.03 billion in 2024 and is expected to reach USD 1.56 billion by 2028, growing at a CAGR of 7.19%
Media Contact:
Company Name: MarkNtel Advisors
Email: sales@marknteladvisors.com
Website: www.marknteladvisors.com/
Phone: +1 628 895 8081, +91 70 4278433
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh - 201301, India
